Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 237 entries
Sorted by: Best Match Show Resources per page
Media pedagogy: New technologies and visual culture in postwar education

pedagogy

Goldfarb BD.
GSID: -PcftHnFuJMJ
BD Goldfarb - 1998 - search.proquest.com

This dissertation considers the intersections of the theory and practice of pedagogy and new (postwar) media technologies and media uses. I begin with the premise that pedagogical …

Cite
Goldfarb, B. D. (1998). Media pedagogy: New technologies and visual culture in postwar education. University of Rochester.
Goldfarb, Brian D. Media pedagogy: New technologies and visual culture in postwar education. University of Rochester, 1998.
Copy Download .nbib Format: MLA
Shear instabilities in granular flows.

Nature

Goldfarb DJ, Glasser BJ, Shinbrot T.
PMID: 11797003
Nature. 2002 Jan 17;415(6869):302-5. doi: 10.1038/415302a.

Unstable waves have been long studied in fluid shear layers. These waves affect transport in the atmosphere and oceans, in addition to slipstream stability behind ships, aeroplanes and heat-transfer devices. Corresponding instabilities in granular flows have not been previously...

Cite
Goldfarb DJ, Glasser BJ, Shinbrot T. Shear instabilities in granular flows. Nature. 2002;415(6869):302-5doi: 10.1038/415302a.
Goldfarb, D. J., Glasser, B. J., & Shinbrot, T. (2002). Shear instabilities in granular flows. Nature, 415(6869), 302-5. https://doi.org/10.1038/415302a
Goldfarb, David J, et al. "Shear instabilities in granular flows." Nature vol. 415,6869 (2002): 302-5. doi: https://doi.org/10.1038/415302a
Goldfarb DJ, Glasser BJ, Shinbrot T. Shear instabilities in granular flows. Nature. 2002 Jan 17;415(6869):302-5. doi: 10.1038/415302a. PMID: 11797003.
Copy Download .nbib Format: NLM
PLASMA CLOT TENSILE STRENGTH MEASUREMENT: ITS RELATION TO PLASMA FIBRINOGEN.

The Journal of clinical investigation

Goldfarb AI, Tarlov IM, Bojar S, Wiener AS.
PMID: 16694992
J Clin Invest. 1943 Mar;22(2):183-90. doi: 10.1172/JCI101381.

No abstract available.

Cite
Goldfarb AI, Tarlov IM, Bojar S, et al. PLASMA CLOT TENSILE STRENGTH MEASUREMENT: ITS RELATION TO PLASMA FIBRINOGEN. J Clin Invest. 1943;22(2):183-90doi: 10.1172/JCI101381.
Goldfarb, A. I., Tarlov, I. M., Bojar, S., & Wiener, A. S. (1943). PLASMA CLOT TENSILE STRENGTH MEASUREMENT: ITS RELATION TO PLASMA FIBRINOGEN. The Journal of clinical investigation, 22(2), 183-90. https://doi.org/10.1172/JCI101381
Goldfarb, A I, et al. "PLASMA CLOT TENSILE STRENGTH MEASUREMENT: ITS RELATION TO PLASMA FIBRINOGEN." The Journal of clinical investigation vol. 22,2 (1943): 183-90. doi: https://doi.org/10.1172/JCI101381
Goldfarb AI, Tarlov IM, Bojar S, Wiener AS. PLASMA CLOT TENSILE STRENGTH MEASUREMENT: ITS RELATION TO PLASMA FIBRINOGEN. J Clin Invest. 1943 Mar;22(2):183-90. doi: 10.1172/JCI101381. PMID: 16694992; PMCID: PMC435225.
Copy Download .nbib Format: NLM
Use of heparin and protamine sulfate during laparoscopic donor nephrectomy.

The Journal of urology

Goldfarb DA.
PMID: 14558560
J Urol. 2003 Jun;169(6):2433-4. doi: 10.1097/00005392-200306000-00120.

No abstract available.

Cite
Goldfarb DA. Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. J Urol. 2003;169(6):2433-4doi: 10.1097/00005392-200306000-00120.
Goldfarb, D. A. (2003). Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. The Journal of urology, 169(6), 2433-4. https://doi.org/10.1097/00005392-200306000-00120
Goldfarb, David A. "Use of heparin and protamine sulfate during laparoscopic donor nephrectomy." The Journal of urology vol. 169,6 (2003): 2433-4. doi: https://doi.org/10.1097/00005392-200306000-00120
Goldfarb DA. Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. J Urol. 2003 Jun;169(6):2433-4. doi: 10.1097/00005392-200306000-00120. PMID: 14558560.
Copy Download .nbib Format: NLM
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database.

The Journal of urology

Goldfarb DA.
PMID: 14558563
J Urol. 2003 Jun;169(6):2435.

No abstract available.

Cite
Goldfarb DA. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Urol. 2003;169(6):2435
Goldfarb, D. A. (2003). Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. The Journal of urology, 169(6), 2435.
Goldfarb, David A. "Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database." The Journal of urology vol. 169,6 (2003): 2435.
Goldfarb DA. Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Urol. 2003 Jun;169(6):2435. PMID: 14558563.
Copy Download .nbib Format: NLM
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.

The Journal of urology

Goldfarb DA.
PMID: 14558568
J Urol. 2003 Jun;169(6):2436-7.

No abstract available.

Cite
Goldfarb DA. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. J Urol. 2003;169(6):2436-7
Goldfarb, D. A. (2003). Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. The Journal of urology, 169(6), 2436-7.
Goldfarb, David A. "Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity." The Journal of urology vol. 169,6 (2003): 2436-7.
Goldfarb DA. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. J Urol. 2003 Jun;169(6):2436-7. PMID: 14558568.
Copy Download .nbib Format: NLM
Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

International journal of nephrology and renovascular disease

Beara-Lasic L, Pillinger MH, Goldfarb DS.
PMID: 21694922
Int J Nephrol Renovasc Dis. 2010;3:1-10. doi: 10.2147/ijnrd.s5563. Epub 2010 Feb 09.

Gout recently passed rheumatoid arthritis to become the most common inflammatory arthritis in the United States (US). However, epidemiologic studies indicate that the quality of gout management is suboptimal owing to both patient and physician issues. Only three options...

Cite
Beara-Lasic L, Pillinger MH, Goldfarb DS. Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia. Int J Nephrol Renovasc Dis. 2010;3:1-10doi: 10.2147/ijnrd.s5563.
Beara-Lasic, L., Pillinger, M. H., & Goldfarb, D. S. (2010). Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia. International journal of nephrology and renovascular disease, 31-10. https://doi.org/10.2147/ijnrd.s5563
Beara-Lasic, Lada, et al. "Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia." International journal of nephrology and renovascular disease vol. 3 (2010): 1-10. doi: https://doi.org/10.2147/ijnrd.s5563
Beara-Lasic L, Pillinger MH, Goldfarb DS. Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia. Int J Nephrol Renovasc Dis. 2010;3:1-10. doi: 10.2147/ijnrd.s5563. Epub 2010 Feb 09. PMID: 21694922; PMCID: PMC3108781.
Copy Download .nbib Format: NLM
Panel discussion on aging: Discussion.

Bulletin of the New York Academy of Medicine

Goldfarb AI.
PMID: 19312741
Bull N Y Acad Med. 1965 Oct;41(10):1100-1.

No abstract available.

Cite
Goldfarb AI. Panel discussion on aging: Discussion. Bull N Y Acad Med. 1965;41(10):1100-1
Goldfarb, A. I. (1965). Panel discussion on aging: Discussion. Bulletin of the New York Academy of Medicine, 41(10), 1100-1.
Goldfarb, A I. "Panel discussion on aging: Discussion." Bulletin of the New York Academy of Medicine vol. 41,10 (1965): 1100-1.
Goldfarb AI. Panel discussion on aging: Discussion. Bull N Y Acad Med. 1965 Oct;41(10):1100-1. PMID: 19312741; PMCID: PMC1750789.
Copy Download .nbib Format: NLM
Re: desensitization in HLA-incompatible kidney recipients and survival.

The Journal of urology

Goldfarb DA.
PMID: 22494740
J Urol. 2012 May;187(5):1766-7. doi: 10.1016/j.juro.2011.12.037. Epub 2012 Mar 15.

No abstract available.

Cite
Goldfarb DA. Re: desensitization in HLA-incompatible kidney recipients and survival. J Urol. 2012;187(5):1766-7doi: 10.1016/j.juro.2011.12.037.
Goldfarb, D. A. (2012). Re: desensitization in HLA-incompatible kidney recipients and survival. The Journal of urology, 187(5), 1766-7. https://doi.org/10.1016/j.juro.2011.12.037
Goldfarb, David A. "Re: desensitization in HLA-incompatible kidney recipients and survival." The Journal of urology vol. 187,5 (2012): 1766-7. doi: https://doi.org/10.1016/j.juro.2011.12.037
Goldfarb DA. Re: desensitization in HLA-incompatible kidney recipients and survival. J Urol. 2012 May;187(5):1766-7. doi: 10.1016/j.juro.2011.12.037. Epub 2012 Mar 15. PMID: 22494740.
Copy Download .nbib Format: NLM
Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function.

The Journal of urology

Goldfarb DA.
PMID: 22682862
J Urol. 2012 Jul;188(1):232. doi: 10.1016/j.juro.2012.03.077. Epub 2012 May 15.

No abstract available.

Cite
Goldfarb DA. Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function. J Urol. 2012;188(1):232doi: 10.1016/j.juro.2012.03.077.
Goldfarb, D. A. (2012). Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function. The Journal of urology, 188(1), 232. https://doi.org/10.1016/j.juro.2012.03.077
Goldfarb, David A. "Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function." The Journal of urology vol. 188,1 (2012): 232. doi: https://doi.org/10.1016/j.juro.2012.03.077
Goldfarb DA. Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function. J Urol. 2012 Jul;188(1):232. doi: 10.1016/j.juro.2012.03.077. Epub 2012 May 15. PMID: 22682862.
Copy Download .nbib Format: NLM
Takotsubo Syndrome in African American vs. Non-African American Women.

The western journal of emergency medicine

Qaqa A, Daoko J, Jallad N, Aburomeh O, Goldfarb I, Shamoon F.
PMID: 21691531
West J Emerg Med. 2011 May;12(2):218-23.

OBJECTIVES: Takotsubo syndrome (TTS) is a reversible cause of heart failure rarely described in African-American patients. This study aimed to compare and contrast the clinical characteristics of TTS in African-American (AA) and non-African-American (NAA) patients.METHODS: We retrospectively reviewed the...

Cite
Qaqa A, Daoko J, Jallad N, et al. Takotsubo Syndrome in African American vs. Non-African American Women. West J Emerg Med. 2011;12(2):218-23
Qaqa, A., Daoko, J., Jallad, N., Aburomeh, O., Goldfarb, I., & Shamoon, F. (2011). Takotsubo Syndrome in African American vs. Non-African American Women. The western journal of emergency medicine, 12(2), 218-23.
Qaqa, Ashraf, et al. "Takotsubo Syndrome in African American vs. Non-African American Women." The western journal of emergency medicine vol. 12,2 (2011): 218-23.
Qaqa A, Daoko J, Jallad N, Aburomeh O, Goldfarb I, Shamoon F. Takotsubo Syndrome in African American vs. Non-African American Women. West J Emerg Med. 2011 May;12(2):218-23. PMID: 21691531; PMCID: PMC3099612.
Copy Download .nbib Format: NLM
Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients.

Nephron extra

Nguyen TV, Goldfarb DS.
PMID: 22470394
Nephron Extra. 2011 Jan;1(1):212-6. doi: 10.1159/000334228. Epub 2011 Nov 11.

BACKGROUND: Patients treated with erythropoiesis-stimulating agents (ESAs) to a hemoglobin (Hb) level >12.0 g/dl have increased risk of multiple complications, including death. The optimal Hb target for ESA use has not been established. We hypothesized that reducing the target...

Cite
Nguyen TV, Goldfarb DS. Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients. Nephron Extra. 2011;1(1):212-6doi: 10.1159/000334228.
Nguyen, T. V., & Goldfarb, D. S. (2011). Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients. Nephron extra, 1(1), 212-6. https://doi.org/10.1159/000334228
Nguyen, Timothy V, and Goldfarb, David S. "Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients." Nephron extra vol. 1,1 (2011): 212-6. doi: https://doi.org/10.1159/000334228
Nguyen TV, Goldfarb DS. Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patients. Nephron Extra. 2011 Jan;1(1):212-6. doi: 10.1159/000334228. Epub 2011 Nov 11. PMID: 22470394; PMCID: PMC3290836.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 237 entries